华大智造2025年净利预亏2.21亿—2.73亿元

Core Viewpoint - The company, BGI Genomics (688114), forecasts a net profit loss of between -273 million to -221 million yuan for the year 2025, indicating a year-on-year reduction in losses by 54.56% to 63.22% [1] Financial Performance - The projected net profit loss for 2025 is estimated to be between -273 million yuan and -221 million yuan [1] - This represents a significant improvement in loss reduction compared to the previous year, with a decrease of 54.56% to 63.22% [1] Reasons for Performance Changes - The company has implemented a series of measures aimed at improving quality and efficiency, which include enhancing employee productivity, focusing on research and development, and managing marketing expenses throughout the cycle, leading to a reduction in costs compared to the same period last year [1] - Fluctuations in the exchange rates of the US dollar and euro have resulted in an increase in foreign exchange gains from monetary items held by the company [1] - The company has reversed tax provisions related to uncertainties from previous years, resulting in a decrease in income tax expenses year-on-year [1] - In accordance with accounting standards and company policies, the company has made provisions for asset impairments based on the principle of prudence [1]